oncologypro.esmo.org...1137 patients with metastatic colorectal cancer overall survival among...

47

Upload: others

Post on 05-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 2: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 3: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 4: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 5: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 6: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 7: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 8: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 9: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 10: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 11: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 12: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 13: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 14: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 15: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 16: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 17: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 18: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 19: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 20: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 21: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 22: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 23: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 24: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 25: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 26: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 27: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 28: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 29: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 30: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 31: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 32: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 33: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 34: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 35: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 36: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 37: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 38: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 39: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 40: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 41: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 42: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 43: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 44: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 45: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 46: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,
Page 47: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,